Carol B. Toris

6.2k total citations
125 papers, 4.0k citations indexed

About

Carol B. Toris is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Carol B. Toris has authored 125 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Ophthalmology, 51 papers in Radiology, Nuclear Medicine and Imaging and 36 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Carol B. Toris's work include Glaucoma and retinal disorders (106 papers), Retinal Diseases and Treatments (42 papers) and Corneal surgery and disorders (40 papers). Carol B. Toris is often cited by papers focused on Glaucoma and retinal disorders (106 papers), Retinal Diseases and Treatments (42 papers) and Corneal surgery and disorders (40 papers). Carol B. Toris collaborates with scholars based in United States, China and Canada. Carol B. Toris's co-authors include Carl B. Camras, Michael E. Yablonski, Jonathan E. Pederson, Paul L. Kaufman, B’Ann T. Gabelt, Shan Fan, G. Zhan, Vikas Gulati, Robert N. Weinreb and James D. Lindsey and has published in prestigious journals such as Journal of Personality and Social Psychology, The Journal of Comparative Neurology and Ophthalmology.

In The Last Decade

Carol B. Toris

122 papers receiving 3.8k citations

Peers

Carol B. Toris
S. M. Podos United States
Mark O.M. Tso United States
Louis DeSantis United States
J Cermák United States
S. M. Podos United States
Carol B. Toris
Citations per year, relative to Carol B. Toris Carol B. Toris (= 1×) peers S. M. Podos

Countries citing papers authored by Carol B. Toris

Since Specialization
Citations

This map shows the geographic impact of Carol B. Toris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol B. Toris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol B. Toris more than expected).

Fields of papers citing papers by Carol B. Toris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol B. Toris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol B. Toris. The network helps show where Carol B. Toris may publish in the future.

Co-authorship network of co-authors of Carol B. Toris

This figure shows the co-authorship network connecting the top 25 collaborators of Carol B. Toris. A scholar is included among the top collaborators of Carol B. Toris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol B. Toris. Carol B. Toris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Reed, David M., et al.. (2025). Understanding Individual Intraocular Pressure Response to Treatment with Latanoprost and Timolol. Journal of Ocular Pharmacology and Therapeutics. 41(5). 251–258. 2 indexed citations
3.
Fan, Shan, Vikas Gulati, Haiyan Gong, et al.. (2024). IOP Reduction in Nonhuman Primates by Microneedle Injection of Drug-Free Hydrogel to Expand the Suprachoroidal Space. Translational Vision Science & Technology. 13(10). 14–14. 1 indexed citations
4.
Bastia, Elena, Douglas A. Hubatsch, Carol B. Toris, et al.. (2023). NCX 470 Reduces Intraocular Pressure More Effectively Than Lumigan in Dogs and Enhances Conventional and Uveoscleral Outflow in Non-Human Primates and Human Trabecular Meshwork/Schlemm's Canal Constructs. Journal of Ocular Pharmacology and Therapeutics. 40(6). 389–396.
5.
Fan, Shan, et al.. (2022). Changes in Ocular Biometric Parameters Over a 24-Hour Period in Ocular Hypertensive Patients. Journal of Ocular Pharmacology and Therapeutics. 38(7). 489–495. 2 indexed citations
6.
Komáromy, András M., Douglas W Esson, Ronald L. Fellman, et al.. (2019). The future of canine glaucoma therapy. Veterinary Ophthalmology. 22(5). 726–740. 45 indexed citations
7.
Woodward, David F., Jenny W. Wang, Robert A. Coleman, et al.. (2019). A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method. Journal of Ocular Pharmacology and Therapeutics. 35(5). 265–277. 10 indexed citations
8.
Pattabiraman, Padmanabhan P., et al.. (2019). Clusterin-Cathepsin K Signaling in Trabecular Meshwork Outflow Pathway Regulates Intraocular Pressure. Investigative Ophthalmology & Visual Science. 60(9). 5157–5157. 2 indexed citations
9.
Patel, Pooja, Alon Harris, Carol B. Toris, et al.. (2018). Effects of Sex Hormones on Ocular Blood Flow and Intraocular Pressure in Primary Open Angle Glaucoma: A Review. 1 indexed citations
10.
Toris, Carol B., et al.. (2017). Making Basic Science Studies in Glaucoma More Clinically Relevant: The Need for a Consensus. Journal of Ocular Pharmacology and Therapeutics. 33(7). 501–518. 7 indexed citations
11.
Edwards, Genea, et al.. (2017). Shotgun Sphingolipid Analysis of Human Aqueous Humor. Methods in molecular biology. 1695. 97–107. 3 indexed citations
12.
Razeghinejad, Reza, Shane Havens, Vikas Gulati, et al.. (2016). Intraocular pressure measurement error after corneal procedures in a porcine enucleated eye. Investigative Ophthalmology & Visual Science. 57(12). 6455–6455.
13.
Gong, Haiyan, et al.. (2012). Characterization of Aqueous Humor Outflow through Novel Glaucoma Devices - A Tracer Study. Investigative Ophthalmology & Visual Science. 53(14). 3743–3743. 2 indexed citations
14.
Bastia, Elena, Valerio Chiroli, Carol B. Toris, et al.. (2010). A Novel Nitric Oxide Releasing Prostaglandin Analog, NCX 125, Reduces Intraocular Pressure in Rabbit, Dog, and Primate Models of Glaucoma. Journal of Ocular Pharmacology and Therapeutics. 26(2). 125–132. 59 indexed citations
15.
Lim, Kin Sheng, Cherie B. Nau, Megan M. O’Byrne, et al.. (2008). Mechanism of Action of Bimatoprost, Latanoprost, and Travoprost in Healthy Subjects. Ophthalmology. 115(5). 790–795.e4. 131 indexed citations
16.
Toris, Carol B., et al.. (1999). Effects of Topical Epinephrine on Aqueous Humor Dynamics in the Cat. Experimental Eye Research. 68(4). 439–445. 20 indexed citations
17.
Toris, Carol B. & Carl B. Camras. (1997). Prostaglandins: A new class of aqueous outflow agents. Ophthalmology Clinics of North America. 10(3). 335–355. 6 indexed citations
18.
Toris, Carol B., Carl B. Camras, Michael E. Yablonski, & Valerie Garden. (1997). Acute versus chronic effects of brimonidine on aqueous humor dynamics in human eyes. Investigative Ophthalmology & Visual Science. 38(4). 2 indexed citations
19.
Toris, Carol B., et al.. (1996). Uveoscleral outflow decreases with age in ocular normotensive humans. Investigative Ophthalmology & Visual Science. 37(3). 6 indexed citations
20.
Zhan, G., et al.. (1996). Effect of Nitric Oxide (NO) synthase inhibition on the transient Intraocular Pressure (IOP) increase and Blood-Aqueous Barrier (BAB) breakdown after topically applied prostaglandins (PGs) in rabbits. Investigative Ophthalmology & Visual Science. 37(3). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026